Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_assertion type Assertion NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_head.
- NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_assertion description "[These results support the concept of MKP-1 as a promising negative marker of response to cetuximab-based treatment in CRC patients with wild-type KRAS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_provenance.
- NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_assertion evidence source_evidence_literature NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_provenance.
- NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_assertion SIO_000772 20234366 NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_provenance.
- NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_assertion wasDerivedFrom befree-2016 NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_provenance.
- NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_assertion wasGeneratedBy ECO_0000203 NP800409.RAf5WwaQ4YnH0cTc3peGY74LMOiWLpVou5AXjG0YiXVu8130_provenance.